STOCK TITAN

Clene (CLNN) director awarded 4,098 stock options in Form 4 filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Clene Inc. director Jacobovitz Shalom reported receiving a stock option grant for 4,098 shares of common stock. The option was granted on February 19, 2026 under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share.

The option vests immediately upon grant, meaning it is fully exercisable right away. Following this award, Shalom holds stock options for 4,098 shares, all reported as directly owned. This is a compensation-related equity grant rather than an open-market share purchase.

Positive

  • None.

Negative

  • None.
Insider Jacobovitz Shalom
Role Director
Type Security Shares Price Value
Grant/Award stock option 4,098 $0.00 --
Holdings After Transaction: stock option — 4,098 shares (Direct)
Footnotes (1)
  1. [object Object]
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jacobovitz Shalom

(Last) (First) (Middle)
6550 SOUTH MILLROCK DRIVE
SUITE G50

(Street)
SALT LAKE CITY UT 84121

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
stock option $4.73 02/19/2026 A 4,098 (1) 02/18/2036 common stock 4,098 $0 4,098 D
Explanation of Responses:
1. This option was granted on February 19, 2026 as an option for 4,098 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant.
/s/ Jerome T. Miraglia POA 02/20/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Clene (CLNN) disclose for Jacobovitz Shalom?

Clene reported that director Jacobovitz Shalom received a stock option grant for 4,098 shares of common stock. The award was made as compensation, not an open-market trade, and is reported as directly owned by the director.

How many Clene (CLNN) stock options were granted to Jacobovitz Shalom?

Jacobovitz Shalom was granted stock options covering 4,098 shares of Clene common stock. This entire amount reflects the number of shares underlying the option award reported in the Form 4 insider transaction filing.

What is the exercise price of Jacobovitz Shalom’s Clene (CLNN) stock options?

The stock options granted to Jacobovitz Shalom have an exercise price of $4.73 per share. This is the price at which the director can purchase Clene common stock by exercising the option in the future.

When do Jacobovitz Shalom’s Clene (CLNN) stock options vest?

The options granted to Jacobovitz Shalom vest immediately upon grant. Immediate vesting means the director can exercise the options right away, subject to the terms of the Clene Inc. Amended 2020 Stock Plan.

Under which equity plan were Jacobovitz Shalom’s Clene (CLNN) options granted?

The option grant for Jacobovitz Shalom was issued under the Clene Inc. Amended 2020 Stock Plan. This plan governs the terms of equity awards such as stock options provided to eligible participants, including directors.

How many Clene (CLNN) stock options does Jacobovitz Shalom hold after this grant?

Following this transaction, Jacobovitz Shalom is reported as holding stock options for 4,098 shares of Clene common stock. The Form 4 lists this entire amount as directly owned after the grant.